홈 › 신경교종 › 뉴욕

뉴욕의 신경교종 임상 시험

신경교종 관련 연구 28개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.

뉴욕의 도시

공식 연구 텍스트(영어)

A Study of Mirdametinib in People With Central Nervous System Tumors

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
외 1개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07539441

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
Columbia University Irving Medical Center, New York
Montefiore Medical Center, The Bronx

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07326566

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

NYU Langone Health, New York

피험자 모집 중

18세 ~ 85세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06910306

Observational Connectomics in Adults Undergoing Resection of WHO II-IV Glioma

Lenox Hill Brain Tumor Center, New York

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07927595

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

NYU Langone Health, New York
Columbia University Medical Center, New York

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07703436

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

NYU Langone Health, New York

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07464925

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06810544

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

NYU Langone Health, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT05303519

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT00870129

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, New York
Research Site, New York

피험자 모집 중1/2상

18세 ~ 130세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05417594

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
Memorial Sloan Kettering West Harrison (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
외 1개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT05489783

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

New York University, New York

피험자 모집 중1상

1세 ~ 25세 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT04485559

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

New York Presbyterian Hospital-Columbia University Medical Center, New York

피험자 모집 중4상

18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07486713

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

피험자 모집 중2상

8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
외 1개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05188508

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Memorial Sloan Kettering Cancer Center, New York

피험자 모집 중1/2상

1세 ~ 26세 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT06712875

Chronic CED of TPT for Recurrent Malignant Glioma

Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT06666712

A Study of 177Lu-PSMA-617 in People With Gliomas

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
외 1개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT07223034